Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
---|
03/09/2000 | CA2342205A1 Primate embryonic stem cells with compatible histocompatibility genes |
03/09/2000 | CA2341699A1 A method for the treatment of staphylococcal disease |
03/09/2000 | CA2341522A1 Novel pharmaceutical salt form |
03/09/2000 | CA2341499A1 Pharmaceutical compositions comprising factor xiiia |
03/09/2000 | CA2341412A1 Rationally designed heparinases derived from heparinase i and ii |
03/09/2000 | CA2341409A1 Novel angiogenesis inhibitors |
03/09/2000 | CA2341308A1 Human latent transforming growth factor-.beta. binding protein 3 |
03/09/2000 | CA2340596A1 Guanylate binding protein (gbp-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation |
03/09/2000 | CA2339664A1 Thieno{2,3,-d}pyrimidinedione derivatives and their use as immunosuppressants |
03/08/2000 | EP0983992A2 Compounds having selectivity for retinoid x receptors |
03/08/2000 | EP0983991A2 Compounds having selectivity for retinoid x receptors |
03/08/2000 | EP0983766A1 A pharmaceutical composition for the treatment of rheumatoid disorders comprising sulphur, mustard seeds and a copper salt |
03/08/2000 | EP0983355A1 TUMOUR SUPPRESSOR GENE DBCCR1 AT 9q32-33 |
03/08/2000 | EP0983346A2 Short peptides which selectively modulate the activity of serine/threonine kinases |
03/08/2000 | EP0983267A1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
03/08/2000 | EP0983262A1 Quinoline-4-carboxamide derivatives as nk-2 and nk-3 receptor antagonists |
03/08/2000 | EP0983260A2 3(5)-HETEROARYL SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS |
03/08/2000 | EP0983259A1 Tocopherol esters and their cosmetic and pharmaceutical uses |
03/08/2000 | EP0983258A1 N-hydroxy 4-sulfonyl butanamide compounds |
03/08/2000 | EP0983257A1 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds |
03/08/2000 | EP0983241A1 Cyanoguanidines as cell proliferation inhibitors |
03/08/2000 | EP0983235A2 Leukotriene b 4? derivatives, in particular oximo-ltb 4? antagonists |
03/08/2000 | EP0983234A1 Leukotriene b 4? derivatives, in particular 7-methylcyclohexyl-ltb 4? antagonists |
03/08/2000 | EP0983221A1 Cyclohexanediol derivatives |
03/08/2000 | EP0983085A2 Compositions and means for the treatment of burns and other cutaneous traumas |
03/08/2000 | EP0983080A1 Synthetic, statistic thymus peptide combination and its use as a preparation with immunological and/or endocrinological effect |
03/08/2000 | EP0983078A1 SIALOADHESIN FAMILY 4 cDNA |
03/08/2000 | EP0983054A1 Hair growth compositions and uses |
03/08/2000 | EP0982991A1 Beta lactams as antiproliferative agents |
03/08/2000 | EP0820275A4 Cosmetic melanins |
03/08/2000 | EP0591355B1 Porphycene compounds for photodynamic therapy |
03/08/2000 | CN1246857A Substituted pyrimidinone and pyridinone compounds and their use |
03/08/2000 | CN1246856A Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents |
03/08/2000 | CN1246794A Lactose-free, non-hyproscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine |
03/08/2000 | CN1246791A Compositions and methods for treating or preventing inflammatory diseases |
03/08/2000 | CN1246789A Composition containing free kind sphingol alkali and ceramide and its usage |
03/08/2000 | CN1246475A Corticotropin release factors antagonistic agent |
03/08/2000 | CN1246367A Medicine for treating tinea |
03/08/2000 | CN1246364A Mongolian medicine for treating psoriasis |
03/08/2000 | CN1246344A Antipruritic aerosol |
03/08/2000 | CN1246340A Medicinal powder for treating burn and scald |
03/08/2000 | CN1246337A Exterior-applied medicine for treating chilblains |
03/08/2000 | CN1246331A Hair dye composite for keratin fibre containing cation direction dye and polymer thickening agent |
03/08/2000 | CN1050132C Ginkgotide derivatives |
03/08/2000 | CN1050127C Benocycloheptenes and benzoxepines preparing process thereof and pharmaceutical compositions containing them |
03/08/2000 | CN1050126C Tri-substituted imidazoles compound, process for preparing it and use and pharmaceutical compositions containing them |
03/07/2000 | US6034244 Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4-tetrahydroquinoline carboxylic acids, having an electron withdrawing substituent in the aromatic or heteroaromatic moiety, having retinoid-like biological activity |
03/07/2000 | US6034242 2,4-pentadienoic acid derivatives having retinoid-like biological activity |
03/07/2000 | US6034238 Heterocyclic compounds, their preparation and their use as leucocyte adhesion inhibitors and VLA-4-antagonists |
03/07/2000 | US6034221 Reduced side effects |
03/07/2000 | US6034082 5-azabicyclo(3.1.0)hexylalkyl-2-piperiodones and --glutarimides as neurokinin receptor antagonists |
03/07/2000 | US6033664 Use of a preparation comprising a plasminogen activator to improve wound healing |
03/07/2000 | US6033654 Bonding together tissue with adhesive containing polyfunctional crosslinking agent and protein polymer |
03/07/2000 | CA2108804C Cosmetic or dermato-pharmaceutical composition containing a basic amino acid lauroylmethionate associated with at least a polyphenol |
03/07/2000 | CA2007935C Aromatic keto compounds, the preparation thereof, and drugs and cosmetics containing these |
03/02/2000 | WO2000011478A1 Assays, methods and means for modulating nuclear localisation |
03/02/2000 | WO2000011191A2 Tpl-2/cot kinase and methods of use |
03/02/2000 | WO2000011171A2 Human rna-associated proteins |
03/02/2000 | WO2000011028A2 Anti-inflammatory peptides derived from il-2 and analogues thereof |
03/02/2000 | WO2000011010A1 Phosphoglycolipid and methods for its use |
03/02/2000 | WO2000010993A1 Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors |
03/02/2000 | WO2000010982A1 Quinazoline derivatives and pharmaceutical applications therof |
03/02/2000 | WO2000010981A1 Quinazoline derivatives |
03/02/2000 | WO2000010958A1 Vitamin d3 mimics |
03/02/2000 | WO2000010611A2 Drug targeting |
03/02/2000 | WO2000010592A2 Medicaments for preventing or reducing scarring |
03/02/2000 | WO2000010578A1 STABLE HYPOXIA INDUCIBLE FACTOR-1 alpha AND METHOD OF USE |
03/02/2000 | WO2000010575A1 Use of solar radiation in the form of ointment, cream, lotion or solution for treating dermatosis |
03/02/2000 | WO2000010563A1 Novel substituted triazole compounds |
03/02/2000 | WO2000010548A2 19-nor-vitamin d3 compounds with calcemic activity |
03/02/2000 | WO2000010516A1 Topical anionic salicylate for disorders of the skin |
03/02/2000 | WO1999064063A3 Collagenase application form |
03/02/2000 | WO1999058642A3 Secreted proteins and polynucleotides encoding them |
03/02/2000 | WO1999058555A3 Water-soluble pro-drugs of 2,6-diisopropylphenol analogues |
03/02/2000 | WO1998051662A3 Compounds and methods for the inhibition of the expression of vcam-1 |
03/02/2000 | DE19838848A1 Pyrrolizidinalkaloidfreie Petasites enthaltende Zusammensetzung Pyrrolizidinalkaloidfreie Petasites containing composition |
03/02/2000 | DE19838462A1 Aseptic herbal liquid useful as drink or tincture for poultices |
03/02/2000 | CA2342503A1 Quinazoline derivatives |
03/02/2000 | CA2342162A1 Drug targeting |
03/02/2000 | CA2341370A1 Novel substituted triazole compounds |
03/02/2000 | CA2341357A1 Quinazoline derivatives and pharmaceutical applications therof |
03/02/2000 | CA2340649A1 Phosphoglycolipid and methods for its use |
03/02/2000 | CA2340277A1 Human rna-associated proteins |
03/02/2000 | CA2339775A1 Vitamin d3 mimics |
03/02/2000 | CA2339036A1 Tpl-2/cot kinase and methods of use |
03/02/2000 | CA2338837A1 Assays, methods and means for modulating nuclear localisation |
03/01/2000 | EP0981615A1 Protein kinase c inhibitor-like protein (ipkc-2) |
03/01/2000 | EP0981550A1 Methods for eosinophil depletion and compositions therefor |
03/01/2000 | EP0981523A1 CYCLIC ETHER VITAMIN D3 COMPOUNDS, 1$g(a) (OH) 3-EPI-VITAMIN D3 COMPOUNDS AND USES THEREOF |
03/01/2000 | EP0981355A1 Treatment of chronic inflammatory diseases with cm101/gbs toxin |
03/01/2000 | EP0981343A2 Monoesters of probucol for the treatment of cardiovascular and inflammatory disease |
03/01/2000 | EP0981337A2 Enhanced anti-angiogenic activity of permanently charged derivatives of steroid hormones |
03/01/2000 | EP0981326A1 Personal cleansing compositions |
03/01/2000 | EP0885060A4 Solid and semi-solid hydrocarbon gels and uses thereof |
03/01/2000 | CN1246119A Pyrrolo [3,4-d] pyrimidinone derivatives and their use as medicaments |
03/01/2000 | CN1245712A Medicinal composition for curing acne and folliculitis and its preparation method |
03/01/2000 | CN1245694A Hair-blackening and hair-growing capsule and its preparation method |
03/01/2000 | CN1245681A Solid deodorant composition |
03/01/2000 | CA2246791A1 Treatment of endothelium with somatostatin analogues |
02/29/2000 | US6031080 Chemotactic cytokine |